Sydney, 25 February 2019
Macquarie Group Limited (ASX: MQG; ADR: MQBKY) (“MGL”) today announced its intention to raise $A500 million with the ability to raise more or less, through the offer of Macquarie Group Capital Notes 4 (“MCN4”). MCN4 are expected to be quoted on the Australian Securities Exchange (“ASX”) under the code MQGPD (“Offer”).
MCN4 are fully paid, subordinated, non-cumulative, unsecured, mandatorily convertible and perpetual notes issued by MGL at an Issue Price of $A100 per MCN4. Distributions are scheduled to be paid quarterly in arrears, subject to the Payment Conditions.
MCN4 will qualify as Eligible Capital for Australian Prudential Regulation Authority purposes.
The Offer is consistent with Macquarie’s strategy to actively manage its capital mix and maintain diverse sources of funding.
The Offer is made under a Prospectus which was lodged with the Australian Securities and Investments Commission (“ASIC”) and ASX today.
The Prospectus is available at www.MCN4Offer.com.au, by calling the MCN4 Offer Information Line as per the details below or by emailing MCN4Offer@boardroomlimited.com.au. A replacement Prospectus containing the Margin is expected to be made available on 5 March 2019 (“Replacement Prospectus”) when the Offer opens.
Macquarie Capital (Australia) Limited has been appointed as Sole Arranger and a Joint Lead Manager. ANZ Securities Limited, Citigroup Global Markets Australia Pty Ltd, Commonwealth Bank of Australia, Evans Dixon Corporate Advisory Pty Limited, J.P. Morgan Securities Australia Limited, Morgans Financial Limited, National Australia Bank Limited and Westpac Institutional Bank and have also been appointed as Joint Lead Managers.
The Offer is expected to open on 5 March 2019 and consists of:
Anyone who wants to invest in MCN4 will need to contact their Syndicate Broker (to apply under the Broker Firm Offer) or complete an Application Form (to apply under the Securityholder Offer) that will be available online at www.MCN4Offer.com.au or by calling the MCN4 Offer Information Line, as per the details below, when the Offer opens.
The Closing Date is expected to be 5.00pm (AEDT) on 22 March 2019.
MCN4 are complex and not suitable for all investors. Potential investors should read the Replacement Prospectus in its entirety before deciding whether to apply to invest in MCN4. If any part of the Replacement Prospectus is unclear, we recommend seeking guidance from a financial adviser or other professional adviser.
If you have any questions about MCN4 or the Offer, you should seek advice from your financial adviser or other professional adviser. You can also email the Registrar at MCN4Offer@boardroomlimited.com.au or call the MCN4 Offer Information Line on 1300 005 027 (within Australia) or on +61 2 8023 5474 (outside Australia) (Monday to Friday 8.30am - 5.30pm, AEDT) during the Offer Period. Applicants under the Broker Firm Offer may also call their Syndicate Broker.
|Key dates for the Offer||Date|
|Record date for determining Eligible Securityholders||7.00pm Friday, 22 February 2019|
|Lodgement of the Prospectus with ASIC||Monday, 25 February 2019|
|Bookbuild period commences||Monday, 25 February 2019|
|Announcement of the Margin||Friday, 1 March 2019|
|Lodgement of the Replacement Prospectus with ASIC||Tuesday, 5 March 2019|
|Opening Date||Tuesday, 5 March 2019|
|Closing Date for the Offer||5.00pm Friday, 22 March 2019|
|Issue Date||Wednesday, 27 March 2019|
|MCN4 commence trading on ASX on a deferred settlement basis||Thursday, 28 March 2019|
|Holding Statements despatched by||Monday, 1 April 2019|
|MCN4 commence trading on ASX on a normal settlement basis||Tuesday, 2 April 2019|
|Key dates for MCN4||Date|
|First distribution payment date||11 June 2019|
|Scheduled optional exchange dates||10 September 2026, 10 March 2027 and 10 September 2027|
|Scheduled mandatory exchange date||10 September 2029|
These dates are indicative only and may change without notice.
MGL, with the prior consent of the Joint Lead Managers may vary the timetable, including by extending any Closing Date, closing the Offer early without notice or accepting late Applications (whether generally or in particular cases) or withdrawing the Offer at any time before MCN4 are issued, in its discretion. You are strongly encouraged to apply online as soon as possible after the Opening Date to ensure that your Application and Application Payment are received by the Closing Date for the Securityholder Offer.
If you wish to submit your Application via a paper Application Form you must submit your Application Payment by cheque(s) and/or money order(s) so that it is received by the Registrar by the Closing Date for the Securityholder Offer. If you are returning your payment by post you should ensure sufficient time for delivery by postal service or else your Application may not be accepted. Online Application and payment using BPAY® is preferred to ensure the efficient and timely processing of Applications.
Unless otherwise defined, capitalised words used in this announcement have the meanings given to them in the Prospectus.
The information provided in this announcement and the Prospectus is not personal investment advice and has been prepared without taking into account your investment objectives, financial situation or particular needs (including financial and taxation issues). It is important that you read the Replacement Prospectus in full before deciding to invest in MCN4 and consider the risks that could affect the performance of MCN4.
Not for distribution or release in the United States
This announcement does not constitute an offer of any securities (including the MCN4) for sale or issue. No action has been taken to register or qualify MCN4 or the Offer or to otherwise permit a public offering of MCN4 outside Australia. In particular, this announcement does not constitute an offer of securities for sale in the United States. Neither the MCN4 nor the Ordinary Shares have been or will be registered under the US Securities Act of 1933, as amended (the “US Securities Act”), or the securities laws of any state or other jurisdiction of the United States, and they may not be offered, sold or resold in the United States except pursuant to an exemption from the registration requirements of the US Securities Act and applicable US State Securities laws.